- The bacterial portion of Nanosphere's (NASDAQ:NSPH) Verigene enteric pathogens nucleic acid test (tests for gastrointestinal infections) has been cleared by the FDA.
- Nanosphere adds clinical studies for the full panel, including two other viral targets, have been finished. Full clearance is expected.